A COMPARISON OF PLACEMENT TECHNIQUES AND COMPLICATIONS OF EXTERNALIZED CATHETERS AND IMPLANTABLE PORT USE IN CHILDREN WITH CANCER

被引:77
作者
MIRRO, J
RAO, BN
KUMAR, M
RAFFERTY, M
HANCOCK, M
AUSTIN, BA
FAIRCLOUGH, D
LOBE, TE
机构
[1] ST JUDE CHILDRENS RES HOSP, DEPT SURG, MEMPHIS, TN 38101 USA
[2] ST JUDE CHILDRENS RES HOSP, DEPT NURSING, MEMPHIS, TN 38101 USA
[3] ST JUDE CHILDRENS RES HOSP, DEPT BIOSTAT, MEMPHIS, TN 38101 USA
[4] UNIV TENNESSEE, CTR HLTH SCI, DEPT PEDIAT, MEMPHIS, TN 38163 USA
[5] UNIV TENNESSEE, CTR HLTH SCI, DEPT SURG, MEMPHIS, TN 38163 USA
关键词
Broviac catheters; Central venous access devices; Hickman catheters; implantable ports;
D O I
10.1016/S0022-3468(05)80176-9
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
The complications associated with the placement and use of Hickman catheters (n=120). Broviac catherers (n=146), and implantable ports (n=93) in children with cancer were analyzed. Percutaneously placed central venous access devices (CVADs) tended to fail less often (P=.86) and to develop infections less often (P=.056) than surgically placed CVADs. The difference im complications with percutaneous versus surgically placed CVADs requires confirmation in a randomized trial to assure they are not a result of differences in patient characteristics. When all catheter failures (removal due to infection, obstruction, or dislodgement) were considered, ports had a significantly longer failure-free duration of use than externalized Hickman and Broviac catheters (P=.0009). Ports also remained infection-free longer than externalized catheters (P=.0014). The greatest risk of infection occurs in the first 100 days of use, particularly for ports. This study demonstrates that for long-term use (greater than 100 days) ports are superior to externalized catheters in children with cancer. © 1990 W.B. Saunders Company.
引用
收藏
页码:120 / 124
页数:5
相关论文
共 28 条
  • [1] BECTON DL, 1988, CANCER, V61, P376, DOI 10.1002/1097-0142(19880115)61:2<376::AID-CNCR2820610229>3.0.CO
  • [2] 2-Y
  • [3] BENEZRA D, 1988, AM J MED, V85, P495
  • [4] BRINCKER H, 1986, CANCER, V57, P1124, DOI 10.1002/1097-0142(19860315)57:6<1124::AID-CNCR2820570611>3.0.CO
  • [5] 2-D
  • [6] BROTHERS TE, 1988, SURG GYNECOL OBSTET, V166, P295
  • [7] BROVIAC JW, 1973, SURG GYNECOL OBSTET, V136, P602
  • [8] LONG-TERM USE OF INDWELLING MULTIPURPOSE SILASTIC CATHETERS IN PEDIATRIC CANCER-PATIENTS TREATED WITH AGGRESSIVE CHEMOTHERAPY
    CAIRO, MS
    SPOONER, S
    SOWDEN, L
    BENNETTS, GA
    TOWNE, B
    HODDER, F
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (05) : 784 - 788
  • [9] DAVIS SJ, 1984, AM SURGEON, V50, P673
  • [10] INSITU MANAGEMENT OF CONFIRMED CENTRAL VENOUS CATHETER-RELATED BACTEREMIA
    FLYNN, PM
    SHENEP, JL
    STOKES, DC
    BARRETT, FF
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1987, 6 (08) : 729 - 734